EndoPredict versus uPA/PAI-1 in breast cancer: Comparison of markers and association with clinicopathological parameters.
Jakubowicz, Elżbieta
EndoPredict versus uPA/PAI-1 in breast cancer: Comparison of markers and association with clinicopathological parameters. [electronic resource] - The breast journal 05 2019 - 450-454 p. digital
Publication Type: Comparative Study; Journal Article
1524-4741
10.1111/tbj.13258 doi
Biomarkers, Tumor--analysis
Breast Neoplasms--drug therapy
Chemotherapy, Adjuvant
Female
Gene Expression Regulation, Neoplastic
Humans
Middle Aged
Plasminogen Activator Inhibitor 1--analysis
Retrospective Studies
Urokinase-Type Plasminogen Activator--analysis
EndoPredict versus uPA/PAI-1 in breast cancer: Comparison of markers and association with clinicopathological parameters. [electronic resource] - The breast journal 05 2019 - 450-454 p. digital
Publication Type: Comparative Study; Journal Article
1524-4741
10.1111/tbj.13258 doi
Biomarkers, Tumor--analysis
Breast Neoplasms--drug therapy
Chemotherapy, Adjuvant
Female
Gene Expression Regulation, Neoplastic
Humans
Middle Aged
Plasminogen Activator Inhibitor 1--analysis
Retrospective Studies
Urokinase-Type Plasminogen Activator--analysis